Data from the ASCENT study of LIQ861 (YUTREPIA™) in PH-ILD patients highlights safety, tolerability, exploratory changes in six-minute walk ...

Biosciences, announced that its collaboration partner, PeriNess has entered into a Clinical Study Agreement to support an ...

Cassava stock crashes 32% as its investigational Alzheimer's disease drug fails to meet the prespecified co-primary endpoints ...

Residents have complained their high quality of life has disintegrated because of the airport; two added to airport noise ...

Alzinova AB (publ) (ticker: ALZ) today announces that the final analysis of data from the Phase 1b clinical study with the vaccine candidate ALZ-101, which included patients with early Alzheimer's dis ...

Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today presented updated preliminary data from Part B of the DeFianCe ...

Eating citrus, like oranges and grapefruits, may lower the risk of developing depression by supporting better gut health. Dr.

It was a busy week in the biotech sector with important regulatory and pipeline updates. Among these, Cassava Sciences, Inc ...

The main findings of the study suggested that those who planned to leave the tour found the transition process easy, whereas those who did not plan to leave the tour found the process difficult. Most ...

InflaRx (NASDAQ:IFRX – Free Report) had its target price hoisted by Guggenheim from $7.00 to $10.00 in a report published on Wednesday morning, Ratings reports. The brokerage currently has a buy ...

NEW HAVEN, Conn., March 27, 2025 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in ...